Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
7 (23%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-ALENDRONATE | 70.0MG | TABLET | Actual shortage | 2024-01-26 | 2024-01-26 | 217366 |
| MINT-AMLODIPINE | 5MG | TABLET | Resolved | 2017-11-21 | 2018-01-11 | 30002 |
| MINT-AMLODIPINE | 10MG | TABLET | Resolved | 2018-04-12 | 2018-05-29 | 45528 |
| MINT-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217369 |
| MINT-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217690 |
| MINT-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217693 |
| MINT-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217696 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-04-08 | 2019-06-15 | 80787 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-24 | 2019-12-09 | 89913 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-10-09 | 2019-11-29 | 95947 |
| MINT-CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-03 | 2019-11-29 | 71041 |
| MINT-CIPROFLOX | 250MG | TABLET | Resolved | 2020-04-25 | 2022-06-06 | 113184 |
| MINT-CIPROFLOX | 500MG | TABLET | Resolved | 2018-07-31 | 2020-03-21 | 57055 |
| MINT-CIPROFLOX | 750MG | TABLET | Resolved | 2020-08-19 | 2022-06-06 | 122502 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-04-27 | 2020-10-10 | 113281 |
| MINT-CITALOPRAM | 20MG | TABLET | Actual shortage | 2020-07-28 | 2023-01-03 | 121276 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-08-19 | 2020-11-11 | 122507 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-11 | 2021-06-22 | 131327 |
| MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2018-04-12 | 2018-05-16 | 45533 |
| MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2020-04-27 | 2020-11-11 | 113285 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
| MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
| MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
| MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |